Title |
Managing inflammatory bowel disease in pregnancy: current perspectives
|
---|---|
Published in |
Clinical and Experimental Gastroenterology, October 2016
|
DOI | 10.2147/ceg.s96676 |
Pubmed ID | |
Authors |
Matthew Pinder, Katie Lummis, Christian P Selinger |
Abstract |
Inflammatory bowel disease (IBD) affects many women of childbearing age. The course of IBD is closely related to pregnancy outcomes with poorly controlled IBD increasing the risk of prematurity, low weight for gestation, and fetal loss. As such, women with IBD face complex decision making weighing the risks of active disease versus those of medical treatments. This review summarizes the current evidence regarding the safety and efficacy of IBD treatments during pregnancy and lactation aiming to provide up-to-date guidance for clinicians. Over 50% of women have poor IBD- and pregnancy-related knowledge, which is associated with views contrary to medical evidence and voluntary childlessness. This review highlights the effects of poor patient knowledge and critically evaluates interventions for improving patient knowledge and outcomes. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 78 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 23% |
Student > Bachelor | 9 | 12% |
Student > Ph. D. Student | 7 | 9% |
Student > Postgraduate | 6 | 8% |
Other | 5 | 6% |
Other | 16 | 21% |
Unknown | 17 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 32 | 41% |
Nursing and Health Professions | 15 | 19% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Computer Science | 2 | 3% |
Psychology | 2 | 3% |
Other | 5 | 6% |
Unknown | 20 | 26% |